TGF-beta 1

TGF-beta 1 Overview

English NameTransforming growth factor beta 1Approved Drugs1
Drugs in Clinical Trials21Target SynonymLatency-Associated Peptide,IBDIMDE,Transforming Growth Factor beta1,Prepro-Transforming Growth Factor Beta-1,TGF-Beta-1,Transforming Growth Factor, Beta 1,CED,TGFB,DPD1,TGFB1,Transforming Growth Factor Beta-1 Proprotein,Camurati-Engelmann Disease,LAP,TGFbeta,Transforming Growth Factor Beta 1,Diaphyseal Dysplasia 1, Progressive,TGF-Beta1
Highest Development StageApproved
English NameTransforming growth factor beta 1
Target SynonymLatency-Associated Peptide,IBDIMDE,Transforming Growth Factor beta1,Prepro-Transforming Growth Factor Beta-1,TGF-Beta-1,Transforming Growth Factor, Beta 1,CED,TGFB,DPD1,TGFB1,Transforming Growth Factor Beta-1 Proprotein,Camurati-Engelmann Disease,LAP,TGFbeta,Transforming Growth Factor Beta 1,Diaphyseal Dysplasia 1, Progressive,TGF-Beta1
Approved Drugs1
Drugs in Clinical Trials21
Highest Development StageApproved

TGF-beta 1 Product List

  • Product Category

    Protein (8)Cell (1)

  • Product Status

    Launched (9)

  • Species

    Human (6)Mouse / Rat (3)

  • Tag

    Tag Free (6)Avi Tag (2)- (1)

  • Conjugate

    Unconjugated (6)Biotin-labeled (2)- (1)

TGF-beta 1 Background

Transforming growth factor beta 1 ( TGFB1) is also known as TGF-β1, CED, DPD1, TGFB. is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation and apoptosis. The TGFB1 protein helps control the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), cell movement (motility), and the self-destruction of cells (apoptosis). The TGFB1 protein is found throughout the body and plays a role in development before birth, the formation of blood vessels, the regulation of muscle tissue and body fat development, wound healing, and immune system function. TGFB1 is particularly abundant in tissues that make up the skeleton, where it helps regulate bone growth, and in the intricate lattice that forms in the spaces between cells (the extracellular matrix). Within cells, this protein is turned off (inactive) until it receives a chemical signal to become active. TGFB1 plays an important role in controlling the immune system, and shows different activities on different types of cell, or cells at different developmental stages. Most immune cells (or leukocytes) secrete TGFB1. TGFB1 has been shown to interact with TGF beta receptor 1, LTBP1, YWHAE, EIF3I and Decorin.

TGF-beta 1 Synonyms

CEDLAP,TGF-beta 1,TGFB1,DPD1,TGF-beta-1,TGFB

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
VactosertibTEW-7197; EW-7197; NOV-1301Phase 3 ClinicalMedpacto IncSolid tumours; Stomach Neoplasms; Esophageal Neoplasms; Carcinoma, Transitional Cell; Myelodysplastic Syndromes; Myeloproliferative Disorders; Osteosarcoma; Colorectal Neoplasms; Urologic Neoplasms; Esophageal adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma; Adenocarcinoma
Details
Bintrafusp alfaM-7824; GSK-4045154; MSB-0011359CPhase 3 ClinicalMerck SeronoBrain metastases; Cholangiocarcinoma; Breast Neoplasms; Microsatellite Instability; Vulvar Neoplasms; Sarcoma; Nasopharyngeal Carcinoma; Prostatic Neoplasms; Colorectal Neoplasms; Thymus Neoplasms; Oropharyngeal Neoplasms; Gallbladder Neoplasms; Lung Neoplasms; Prostatic Neoplasms, Castration-Resistant; Lymphoma; Penile Neoplasms; Thymoma; Urogenital Neoplasms; Metastatic breast cancer; Carcinoma, Small Cell; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma; Neoplasm Metastasis; Sarcoma, Kaposi; Neoplasms, Germ Cell and Embryonal; Stomach Neoplasms; Solid tumours; Hematologic Neoplasms; Head and Neck Neoplasms; Intestinal Neoplasms; Skin Melanoma; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Vaginal Neoplasms; Carcinoma; Carcinoma, Renal Cell; Esthesioneuroblastoma, Olfactory; Anus Neoplasms; Biliary Tract Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Nose Neoplasms; Ganglioglioma; Papillomavirus Infections; Carcinoma, Trans
Details
NisevokitugNIS-793Phase 3 ClinicalXoma CorpKidney Neoplasms; Polycythemia Vera; Pancreatic Neoplasms; Myelodysplastic Syndromes; Breast Neoplasms; Colorectal Neoplasms; Primary Myelofibrosis; Carcinoma, Pancreatic Ductal; Lung Neoplasms; Adenocarcinoma; Thrombocythemia, Essential; Carcinoma, Hepatocellular
Details
SB-01 (Ensol BioSciences)Peniel-2000; SB-01; Peniel 2K; YH14618; YH-14618; P2KPhase 3 ClinicalEnsol Biosciences IncIntervertebral Disc Degeneration; Intervertebral disc disease; Low Back Pain
Details
LivmoniplimabMGH-8; AGRX-115; ABBV-151; MHG-8; ARGX-115Phase 3 ClinicalArgenx SeSolid tumours; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular
Details
Dalutrafusp alfaGS-1423; AGEN-1423Phase 2 ClinicalAgenus IncSolid tumours; Liver Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal
Details
ZSP-1603ZSP-1603Phase 2 ClinicalWuxi Apptec Co Ltd, Guangdong Zhongsheng Pharmaceutical Co LtdOvarian Neoplasms; Liver Neoplasms; Solid tumours; Carcinoma, Renal Cell; Idiopathic Pulmonary Fibrosis; Colonic Neoplasms; Thyroid Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
NicousamideXLF-III-43Phase 2 ClinicalInstitue Of Materia Medica Chinese Academy Of Medical ScienceHypertensive nephropathy; Diabetic Nephropathies
Details
Meflonidone hydrochloridePhase 2 ClinicalGuangzhou Nanxin Pharma Co Ltd, Central South UniversityDiabetes Mellitus, Type 2; Diabetic Nephropathies
Details
FluorofenidoneAKF-PDPhase 2 ClinicalDierepharma HK Ltd, Hainan Haiyao Co Ltd, Central South UniversityHepatitis B, Chronic; Liver Cirrhosis
Details
CotsiranibSTP-705LU; STP-705LV; STP-705; STP-705LPhase 2 ClinicalSirnaomics, Sirnaomics Biopharmaceuticals (Suzhou) Co LtdLiver Neoplasms; Carcinoma, Basal Cell; Cholangiocarcinoma; Carcinoma, Basosquamous; Obesity, Abdominal; Keloid; Cicatrix, Hypertrophic; Carcinoma, Hepatocellular
Details
Yinfenidone HydrochlorideHEC-585; HEC-00000585Phase 2 ClinicalHec Pharm Co LtdIdiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial; Pulmonary Fibrosis
Details
YL-13027YL-13027Phase 2 ClinicalYL-PharmaSolid tumours; Pancreatic Neoplasms
Details
LinavonkibartSRK-181; SRT-BETA-1-AB3Phase 1 ClinicalScholar Rock IncNeoplasms
Details
Charis-1000Charis-1000; C 1K; C1KPhase 1 ClinicalEnsol Biosciences IncBreast Neoplasms
Details
HLX-6018HLX-6018; HLX6018Phase 1 ClinicalShanghai Henlius Biopharmaceuticals Co Ltd, Shanghai Henlius Biotech IncIdiopathic Pulmonary Fibrosis
Details
RO7496353RO7496353; RO-7496353; SOF 10; RG6440; RG-6440Phase 1 ClinicalGenentech IncSolid tumours; Stomach Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung
Details
JYB-1907JYB-1907Phase 1 ClinicalJiangxi Jemincare Group Co LtdSolid tumours
Details
STP-707STP-707; STP707Phase 1 ClinicalSirnaomics Biopharmaceuticals (Suzhou) Co LtdLiver Neoplasms; Solid tumours; Pancreatic Neoplasms; Liver Cirrhosis; Pulmonary Fibrosis; Cholangitis, Sclerosing
Details
PXS-64PXS-64Phase 1 ClinicalSyntara LtdMultiple Sclerosis
Details
AVID-200AVID-200; BMS-986416; AVID-200 DPPhase 1 ClinicalFormation Biologics CorpSolid tumours; Polycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Thrombocythemia, Essential
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Tonogenchoncel-LTG-CApprovedTissuegeneInvossa-K, InvossaSouth KoreaOsteoarthritisnull2017-07-01Intervertebral Disc Degeneration; Osteoarthritis, Knee; Osteoarthritis
Details

Product Reviews

  • Y***G2025-11-07
    0People Like
    1. Good protein activity! Purchased this protein multiple times.
  • 1***22019-10-12
    3People Like
    The TGFb1 protein was used as the negative comparing group in T-cell suppression experiments. The protein has a good bioactivity at suppressing T-cells by significantly inhibiting the proliferation of T-cells stimulated by anti-CD3. The repeatability and stability of the experiment was pretty good.
  • Overview
  • Product List
  • Marketed Drug Information
  • Product Reviews
  • Clinical Drug Information